09

• Establishment of a laboratory venture corporation
• Business registration completed

12

• Incorporated the University of Seoul technology holding company as a subsidiary (attracted 10% equity investment)
• Acquisition of transparent nerve electrode patent
• Commercialization of opaque nerve electrodes and related materials
• Achieved KRW 32 million in sales in 2021

01

• Certified as a venture company
• Korea Technology Finance Corporation U-Tech Valley Guarantee Certification (Limit of KRW 3 billion)
• Attracted the first overseas customer (1 NDA, USD 2500 contract)

05

• Selected as an initial start-up package project by the Korea Institute of Startup & Entrepreneurship Development

07

• Established University of Seoul Campus Town Branch

10

• Developed two new bio electrode products

11

• Selected as Seoul Institute of Technology Campus Town Technology Matching Business

• Developed 2 new products
• Improved website
• Improved bioelectrode productivity
• Secured size/structure design technology for diversifying electrode applications
• Achieved over KRW 100 million in sales

• Continuous R&D and sales growth through primary and secondary customers
• Developing bioelectrode application items (Expansion of functions by adding peripheral circuits)
• Securing private investment (Targeting corporate value of over KRW 50 billion by 2027)